Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome

Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome

Abstract Background Antiplatelet therapy is pivotal in managing elderly patients with Acute Coronary Syndrome (ACS) following Percutaneous Coronary Intervention (PCI). While aspirin remains a cornerstone of this therapy, its use is sometimes limited by the risk of gastrointestinal (GI) complications...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenbo Dai, Guanyu Mu, Jiayi Ren, Sutao Hu, Rongxin Guo, Tian-shu Gu, Jingjin Che, Xianghong Ma, Tong Liu, Xue Wu, Jing-Kun Zhang, Gary Tse, Yajie Wang, Jian-Mei Zhou, Seung-Woon Rha, Kangyin Chen
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Indobufen
Aspirin
Percutaneous coronary intervention
Acute coronary syndrome
Elderly patients
Online Access:https://doi.org/10.1186/s12872-025-04843-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12872-025-04843-0

Similar Items